Merck announced that following the final approval of the European Commission it is set to complete its $17 billion (€13.1 billion) acquisition of Sigma-Aldrich.
The European Commission had granted conditional approval to the acquisition of Sigma-Aldrich on June 15, 2015, subject to the divestment of certain Sigma-Aldrich assets. On October 20, 2015, Merck announced an agreement to sell parts of Sigma-Aldrich’s solvents and inorganics business to Honeywell. Now that the European Commission has approved that transaction, all necessary closing requirements have been fulfilled for Merck to complete the acquisition of Sigma-Aldrich. The formal completion date is scheduled for November 18, with the delisting of Sigma-Aldrich’s stock from NASDAQ taking effect following completion.
“We’ve reached the home stretch and are set to complete the largest acquisition in our almost 350-year history,” said Karl-Ludwig Kley, CEO and Chairman of Merck.
Merck and Sigma-Aldrich announced on September 22, 2014 that they had entered into a definitive agreement under which Merck would acquire all outstanding shares of Sigma-Aldrich for $140 per share in cash. Today’s final approval of the European Commission follows the approval of the acquisition by Sigma-Aldrich’s shareholders at a special meeting held on December 5, 2014 and the satisfaction of other customary conditions, including antitrust clearance in the United States, China, Japan and several other countries.
Merck, has entered an expanded partnership with global green chemistry education nonprofit Beyond Benign. With plans for a multi-year contribution to the organization, Merck is helping transform chemistry education to better prepare next generation scientists with skills to address sustaina ... more
Fiscal 2022: Merck Delivers Profitable Growth Despite Challenges
Merck delivered profitable growth despite challenges in fiscal 2022. Group net sales increased by 12.9% (organically: 6.4%) to € 22,232 million compared with the previous year. Sales growth was driven by all regions and business sectors, particularly Life Science. The Big 3 businesses – Pro ... more
Merck Further Expands its Semiconductor Solutions Capacities Globally
Merck is breaking ground in Kaohsiung, Taiwan, for a new production facility in its Semiconductor Solutions business. The site, which covers an area of 150,000 m2, is to produce specialty gases and semiconductor materials for thin film and patterning solutions as of 2025. The site is to be ... more
Milli-Q Services for Your Water Purification System
Tailored service plans ✓ Preventive maintenance visits ✓ Traceable and auditable documentations & tools ✓ more
Integrated Water Purification System Delivering Type 1 and Type 2 Water Direct from Tap Water
Intuitive touchscreen ✓ Simple and intuitive Q-POD and E-POD dispensers ✓ A10 TOC-Monitor ✓ more
Innovative materials for the Battery production
Innovative Battery materials for the development of high-performance, reliable and cost-effective Li-ion batteries more
Milli-Q Services for Your Water Purification System
Our Milli-Q water treatment system is a sophisticated piece of equipment equipped with highly sensitive technologies. We offer tailored service plans, preventive maintenance visits and support regulated environments. Through the new MyMilli-Q online solution, you can simplify your equipment ... more
How can you overcome routine administration tasks that steal 40% of your laboratory's valuable time?
This whitepaper demonstrates how digital laboratory productivity technology can liberate scientists to prioritize innovation. more
You’re using surfactants like Triton X-100? The REACH clock is ticking …
In the new Application Note "Comparison of Greener Detergents in Mammalian Cell Lysis & Downstream Applications" more
Measuring environmental impact: Elix® system water purification vs. a distillation apparatus
Long-term environmental sustainability and continued reduction in the consumption of non-renewable raw materials is increasingly important for more
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclero ... more
Merck Completes Sigma-Aldrich Acquisition
Merck announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry. The completion follows last week’s approval from the European Commission, which was the final antitrust condition required to close the Sigma-Al ... more
Merck announces Sigma-Aldrich business sale to Honeywell
Merck announced that Sigma-Aldrich, the U.S. life science company it plans to acquire, agreed to sell parts of its solvents and inorganics business in Europe to Honeywell in fulfilment of commitments made to the European Union in order to win antitrust approval for its $17 billion acquisiti ... more
Merck progresses toward completion of Sigma-Aldrich acquisition
Merck announced that it had obtained all necessary antitrust approvals, with the approval of the European Commission being conditional upon the sale of parts of Sigma-Aldrich’s solvents and inorganics business. Negotiations with potential buyers are in the final stage. Once a binding agreem ... more
Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high ... more
Sigma-Aldrich Química, S.A. de C.V.
Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high ... more
